J&J pauses Covid-19 vaccine trials
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
Dispatch from a refugee camp during the COVID-19 pandemic
USD/CAD steady as US inflation dips
Juventus Shares Crash To 6-Month Lows After Ronaldo Tests Positive For COVID
25-Year-Old Nevada Man First American Confirmed To Have Caught COVID-19 Twice
Fastenal Dips Over 5% On 3Q Revenue Miss
Oil enjoying reprieve, gold coming under pressure
Proactivity and partnership pay off for nursing homes in a pandemic, study suggests
Nasdaq Futures Surge Despite Vaccine Setback As Gamma Squeeze Continues
BlackRock Gains 4% On 3Q Profit Beat; Street Says Buy
Itamar Medical To Outperform 3Q Sales Est., Reinstates 2020 Guidance
Record number of health firms feature in UK top 100 private tech list
Exelon Jumps On Possible Non-Utility Divestment; Analyst Sees 50% Upside
Dynavax Surges 7% In Pre-Market On Taiwan Covid-19 Vaccine Subsidy
The World's First Fully Driverless Vehicle Ready To Hit The Roads
Pfizer, BioNTech Ink Deal To Supply 1.5M Covid Vaccines To New Zealand
Can we actually learn to live with coronavirus? Not until we have a vaccine
Altimmune's COVID-19 Vaccine Shows Positive Results; Street Sees 289% Upside
Zynex Tanks 23% As Demand Hit By Covid-19; Street Stays Bullish
Cloudflare Soars 23% After Cloud Platform Launch
Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise
New U.S. Covid-19 cases rise 11% last week, Midwest hard hit
Takeda group begins manufacturing Covid-19 plasma treatment ahead of approval
PerkinElmer Raises 3Q Sales Outlook Fueled By COVID-19 Testing Demand
US Close – Tech’s big week, US consumer will spend this week, Oil’s demand problem, Gold steady despite dollar bounce
South Korea’s Daewoong Pharma gets approval for Phase 1 trials of Covid-19 anti-parasite drug
Coronavirus stimulus checks: Trump may back package larger than Democrats’ bill, Kudlow says
Bob Langer-backed spinout shoots for $75M-plus IPO while biotech SPACs continue to rule on Wall Street
Coronavirus: R number does not measure risk – financial disaster modelling offers a better alternative